Alisha P Maity, MD
Hematology, Medical Oncology
Headshot of Alisha P Maity, MD

Alisha P Maity, MD

Hematology, Medical Oncology
Accepting new patients
Sees patients age 18 and up
Abramson Cancer Center Perelman 2nd Floor West
View 1 additional location
Headshot of Alisha P Maity, MD
Penn Medicine Provider

About me

  • Clinical Assistant Professor of Medicine (Hematology-Oncology)
As a hematology and oncology physician, Dr. Alisha Maity is dedicated to providing compassionate, evidence-based care for patients navigating NETs and GI cancers. Combining strong clinical expertise with an active commitment to research, she strives to ensure that every patient feels informed, supported, and empowered throughout their treatment journey. Her goal is to deliver personalized care that advances health outcomes while preserving dignity, hope, and quality of life.

My education and training

  • Thomas Jefferson UniversityMedical School
  • Lankenau Medical CenterResidency
  • Lankenau Medical CenterFellowship

Spoken languages

English
English

Insurance accepted

Please contact the practice and/or the member services department of your insurance company for specific details before receiving services. Providers may participate in some, but not all, products offered by a health plan; providers may also accept plans at some practice locations but not others.

Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
Dr. Maity is a Penn Medicine provider.

Qualifications and experience

All conditions and treatments

Research

Publications

Maity AP, Kjelstrom S, Gu H, Sanborn M, Kalola A, Savior D, Ghaneie A, Dessain SK. Assessing Guideline-Directed Care in the New Era of Neoadjuvant Therapy in Early-Stage Resectable Non-small Cell Lung Cancer (NSCLC): A Retrospective Review , Clin Lung Cancer: 2026


Maity AP, Kjelstrom SD, Fleck KJ, Zeger EL, Ali ZA, Ghaneie A, Shevade AL, Gilman PB, Savior DC, Wallon UM. Prediction of Moderate to Severe Delayed Chemotherapy-Induced Nausea Using a Novel Algorithm Incorporating Individual Patient Factors , Cancer Med: 2026


Rosenberg M, Maity AP, Shankar K, Dunne C, Ghaneie A. Should monitoring guidelines and decision to treat for I⁠gM MGUS be different when caring for Jehovah's Witness patients? , Clin Hematol Int, 8: 2026,1-6


Sanborn M, Koury M, Maity A, Ali Z. A Rare Cause of Internal Jugular Vein Thrombosis: Deep Tissue Massage , Ochsner J: 2025


Sanborn M, Maity A, Limmonick V, Siddiqui A, Salvatore S, McHugh T. Chromogranin A-Associated Tubulopathy in a Patient With Neuroendocrine Tumor , Cureus, 17: 2025,e99048


Ayub M, Kaminoff L, Maity A, Ali Z. Detailed primary localised cutaneous nodular amyloidosis clinical and pathological workup , BMJ Case Rep, 17: 2024,e262126


Maity AP, Gangireddy M, Degen KC, Al-Saleem FH, Bramson J, Ciocca V, Dessain SK, Evans TL. Impact of Simultaneous Circulating Tumor DNA and Tissue Genotyping in the Workup of Stage IV Lung Adenocarcinoma on Quality of Care in an Academic Community Medical Center , JCO Oncol Pract: 2023


Aggarwal C, Maity AP, Bauml JM, Long Q, Aleman T, Ciunci C, D'Avella C, Volpe M, Anderson E, Jones LM, Sun L, Singh AP, Marmarelis ME, Cohen RB, Langer CJ, Amaravadi R. A Phase II Open-Label Trial of Binimetinib and Hydroxychloroquine in Patients With Advanced KRAS-Mutant Non-Small Cell Lung Cancer , Oncologist, 28: 2023,644-e564


Lombardo J, Ko K, Shimada A, Nelson N, Wright C, Chen J, Maity A, Ruggiero ML, Richard S, Papanagnou D, Mitchell E, Leader A, Simone NL. Perceptions of and barriers to cancer screening by the sexual and gender minority community: a glimpse into the health care disparity , Cancer Causes Control: 2022


Xu MJ, Maity A, Vogel J, Kirk M, Zhai H, Both S, Lin LL. Proton Therapy Reduces Normal Tissue Dose in Extended-Field Pelvic Radiation for Endometrial Cancer , Int J Part Ther: 2018


View all publications